Skip to main content
. 2023 May 4;24(9):8206. doi: 10.3390/ijms24098206

Figure 1.

Figure 1

Targeting HER2 low BC with ADCs—the bystander effect that enables the delivery of the drug to the neighboring cells that do not express HER2, after interstitial linker cleavage and release of membrane-permeable free payload.